Rhys D Brady Selected Research

Seizures (Absence Seizure)

10/2023	E2730, an uncompetitive γ-aminobutyric acid transporter-1 inhibitor, suppresses epileptic seizures in a rat model of chronic mesial temporal lobe epilepsy.
1/2023	Disease-modifying effects of sodium selenate in a model of drug-resistant, temporal lobe epilepsy.
1/2019	Bone Health in Rats With Temporal Lobe Epilepsy in the Absence of Anti-Epileptic Drugs.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Rhys D Brady Research Topics

Disease

11	Traumatic Brain Injuries (Traumatic Brain Injury) 12/2023 - 01/2018
9	Epilepsy (Aura) 11/2023 - 01/2019
6	Post-Traumatic Epilepsy (Epilepsy, Post Traumatic) 11/2023 - 01/2019
6	Wounds and Injuries (Trauma) 12/2021 - 11/2017
5	Brain Concussion (Cerebral Concussion) 11/2023 - 01/2021
4	Brain Injuries (Brain Injury) 12/2023 - 10/2019
4	Multiple Trauma (Multiple Injuries) 01/2023 - 11/2017
3	Seizures (Absence Seizure) 10/2023 - 01/2019
3	Status Epilepticus (Complex Partial Status Epilepticus) 10/2023 - 01/2019
3	Inflammation (Inflammations) 01/2022 - 01/2020
3	Neuroinflammatory Diseases 01/2021 - 11/2017
2	Temporal Lobe Epilepsy 10/2023 - 01/2023
2	Pain (Aches) 01/2021 - 01/2020
2	Edema (Dropsy) 01/2018 - 11/2017
1	Cognitive Dysfunction 01/2023
1	Memory Disorders (Memory Loss) 01/2023
1	Heterotopic Ossification (Ectopic Ossification) 12/2020
1	Chronic Pain 01/2020
1	Apnea 01/2019
1	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 08/2018
1	Tibial Fractures (Fracture, Tibial) 11/2017
1	Atrophy 01/2017
1	Muscular Atrophy (Muscle Atrophy) 01/2017
1	Bone Fractures (Bone Fracture) 10/2014

Drug/Important Bio-Agent (IBA)

16	Biomarkers (Surrogate Marker)IBA 11/2023 - 01/2019
10	salicylhydroxamic acid (SHAM)IBA 12/2023 - 01/2017
4	Proteins (Proteins, Gene)FDA Link 01/2022 - 08/2018
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 11/2023 - 01/2020
2	Kainic Acid (Kainate)IBA 10/2023 - 01/2019
2	Selenic AcidIBA 05/2023 - 01/2023
2	Blood Proteins (Serum Proteins)IBA 01/2022 - 10/2019
1	Bevacizumab (Avastin)FDA Link 11/2023
1	Aminobutyrates (Aminobutyric Acid)IBA 10/2023
1	Protein Phosphatase 2 (Protein Phosphatase 2A)IBA 05/2023
1	von Willebrand FactorIBA 01/2022
1	Fatty Acid-Binding Protein 7IBA 01/2022
1	Claudin-5IBA 01/2022
1	PhosphoproteinsIBA 01/2022
1	Fibrinogen (Factor I)FDA Link 01/2022
1	Anti-Bacterial Agents (Antibiotics)IBA 12/2021
1	Drinking WaterIBA 12/2021
1	Phosphotransferases (Kinase)IBA 01/2021
1	Protein Kinases (Protein Kinase)IBA 01/2021
1	SugarsIBA 01/2021
1	HMGB1 Protein (HMG1)IBA 01/2020
1	N-(2-acetamido)-2-aminoethanesulfonic acid (ACES)IBA 01/2020
1	Hydrocortisone (Cortisol)FDA LinkGeneric 01/2020
1	Dihydrotachysterol (AT 10)IBA 01/2019
1	DNA-Binding Proteins (DNA Binding Protein)IBA 08/2018
1	Messenger RNA (mRNA)IBA 01/2018
1	ChemokinesIBA 01/2018
1	gambogic amideIBA 01/2018
1	Nerve Growth Factor (NGF)IBA 01/2018
1	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 11/2017
1	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 11/2017
1	Peptides (Polypeptides)IBA 10/2014

Therapy/Procedure

9	Therapeutics 11/2023 - 11/2017
2	Operative Surgical Procedures 01/2020 - 10/2019
1	Subcutaneous Infusions 10/2023
1	Withholding Treatment 01/2023
1	Electrodes (Electrode) 01/2019
1	Anesthesia 01/2019